Skip to content

TFL Driven Urinary System Treatment Study

TFL-DUST Study TFL Driven Urinary System Treatment Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06257368
Acronym
TFL-DUST
Enrollment
373
Registered
2024-02-13
Start date
2023-07-24
Completion date
2025-12-31
Last updated
2024-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urologic Diseases

Brief summary

The goal of this observational study is: To assess the use of Coloplast TFL Drive in daily practice To confirm: * the safety and efficacy of the Coloplast TFL Drive and its GUI (Graphical User Interface) with pre-embedded settings in Laser lithotripsy * the safety and efficacy of the Coloplast TFL Drive and its GUI with pre-embedded settings for enucleation of prostate as treatment of benign prostate hyperplasia * the safety and efficacy of the Coloplast TFL Drive and its GUI with pre-embedded settings for ablation of urological tumors

Interventions

DEVICEColoplast TFL Drive

Thulium Fiber laser

Sponsors

Coloplast A/S
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any adult patient, for which TFL laser is indicated for treating a urological disease (e.g. kidney or ureteral stones, urological tumor, BPH (Benign Prostate Hypertrophy…)

Exclusion criteria

* Any condition when TFL laser should not be indicated as per the TFL user manual (untrained surgeon on laser use, patient's conditions) * Patients with no signed consent form * Patients \<18 years old * Patients under tutorship or guardianship * Patients who already took part in the study * Pregnant or breastfeeding women * Patient undergoing 2nd step laser procedure at inclusion * Subject already included in another study

Design outcomes

Primary

MeasureTime frame
Time in Laser ONday 1

Countries

France, Spain

Contacts

Primary ContactJessica Heringer
frhej@coloplast.com+33644287794

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026